Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novocure Stock: Bull vs. Bear

TheMotleyFool

0 0

Many companies like to claim that they have revolutionary, game-changing products. Few live up to the hype.

Novocure (NASDAQ: NVCR) could be an exception. Its tumor-treating fields (TTFields) therapy uses electrical signals to disrupt the division of tumor cells.

But just because a company has a potentially game-changing product doesn't mean that its stock is necessarily a great pick. There are other factors to consider. Is Novocure stock a buy right now? Here are the bull and bear cases.

Source Fool.com

Like: 0

NVCR

Share